Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Natalie Daniels

Dermatology Louisville, KY Medical Doctor

NPI 1396880019 CMS profile 199269

13802 Lake Point Cir Ste 201, Louisville, KY 40223

Open in the dashboard

General payments

$6,072

367 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Natalie Daniels of Louisville, KY is reported in the CMS Open Payments database as having received $6,072 across 367 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $755 35
2024 General $1,068 57
2023 General $857 44
2022 General $1,574 80
2021 General $423 26
2020 General $474 46
2019 General $922 79

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Natalie Daniels
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Natalie Daniels were reported at $755. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Natalie Daniels Dermatology median Middle half National median
2019 $922 $454 $129–$1,240 $163
2020 $474 $235 $81–$756 $114
2021 $423 $377 $108–$1,108 $132
2022 $1,574 $514 $143–$1,391 $149
2023 $857 $607 $159–$1,674 $160
2024 $1,068 $751 $204–$1,903 $164
2025 $755 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $1,403 87 payments
  2. Ortho Dermatologics, a division of Bausch Health US, LLC $478 66 payments
  3. Sun Pharmaceutical Industries Inc. $459 17 payments
  4. Genzyme Corporation $380 17 payments
  5. Galderma Laboratories, L.P. $319 21 payments
  6. Arcutis Biotherapeutics, Inc. $288 19 payments
  7. Incyte Corporation $276 13 payments
  8. Lilly USA, LLC $271 14 payments
  9. Pfizer Inc. $241 14 payments
  10. Mayne Pharma Inc. $172 14 payments
  11. Other $1,785 85 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,059 366 payments
  2. Education $13 1 payment
Products named General payments · program years 2019–2025
  1. SKYRIZI $741 46 payments
  2. DUPIXENT $546 24 payments
  3. RINVOQ $335 24 payments
  4. HUMIRA $306 22 payments
  5. Zoryve $288 19 payments
  6. OPZELURA $276 13 payments
  7. TALTZ $271 14 payments
  8. EBGLYSS $237 12 payments
  9. DUOBRII $200 35 payments
  10. CLODERM $170 6 payments
  11. Other $4,571 249 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

170

Median for Dermatology: 534

Drug cost

$140,482

Median for Dermatology: $67,151

Branded share of claims

24.1%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dupixent Pen Dupilumab Brand 16 $77,662
Otezla Apremilast Brand 12 $57,659
Clobetasol Propionate Generic 52 $2,219
Clindamycin Phosphate Generic 25 $1,967
Econazole Nitrate Generic 17 $439
Ketoconazole Generic 16 $238
Triamcinolone Acetonide Generic 19 $167
Valacyclovir Valacyclovir Hcl Brand 13 $131

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 23 billing codes

Paid by Medicare

$28,617

Of which drugs: $2,417

Medicare patients

186

Average age 73

Services billed

2,517

136 women, 50 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 66%
Arthritis 49%
Diabetes 19%
Ischemic heart disease 19%
Osteoporosis 18%
Atrial fibrillation 15%
Chronic kidney disease 15%
Cancer 12%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 20 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Zoryve
  • Arcutis Biotherapeutics, Inc. $177
$177 — —
DUPIXENT
  • GENZYME CORPORATION $161
$161 16 —
OPZELURA
  • Incyte Corporation $87
$87 — —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $76
$76 — —
ADBRY
  • LEO Pharma Inc. $58
$58 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 20 in the dashboard with a free account

Records

367 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record